No takes yet. Share an insight, caveat, or question.
Immunological study demonstrates that preexisting cross-reactive CD4 T cells enhance SARS-CoV-2 immune responses, suggesting a mechanism for rapid protection and mild COVID-19.
Loyal et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: